3M Pharmaceuticals
Background
In the latter part of 2006, Meda announced completion its acquisition of the pharmaceutical division of 3M in Europe. [1]
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to Graceway Pharmaceuticals Inc. at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to Ironbridge Capital and Archer Capital. [2]
PR, Lobbying and Market Intelligence firms
In 2008, 3M is listed as a client of Innovex[3] and a past or current client of German PR company FischerAppelt Kommunikation[4]
They are a client of lobbying firm Keene Public Affairs Consultants[5] and a former client of Fleishman-Hillard.[6]
The PRCA lobbying register lists 3M as a current client of Cohn and Wolfe Ltd. [7]
Affiliations
3M Pharmaceuticals is listed as a member of the Pharmaceutical Research and Manufacturers of America (PHRMA) in 2005[8] and 2006 [9].3M is also listed as a member of the American Benefits Council[10]
References
- ↑ Zenopa Meda completes 3M Pharmaceuticals acquisition in Europe Accessed 15th December 2007
- ↑ 3M 3M Reaches Agreements to Sell its Pharmaceuticals Business Accessed 15th December 2007
- ↑ Innovex Our Customers Accessed 12th February 2008
- ↑ FischerAppelt Kommunikation Current & former clients Accessed 14th February 2008
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
- ↑ Register Entry for 1 Sep 2011 to 30 Nov 2011 APPC, accessed 28 January 2015
- ↑ Cohn and Wolfe clients, Dec15-Feb16, PRCA, accessed 4 May 2016
- ↑ PHRMA 2005 Industry Profile Accessed 16th December 2007
- ↑ PHRMA 2006 Member Company List Accessed 16th December 2007
- ↑ American Benefits Council Memberships Accessed 26th February 2008
